Depreciation, Depletion and Amortization in USD of Oncocyte Corp from Q1 2020 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Oncocyte Corp quarterly/annual Depreciation, Depletion and Amortization history and change rate from Q1 2020 to Q3 2025.
- Oncocyte Corp Depreciation, Depletion and Amortization for the quarter ending September 30, 2025 was $584K, a 71.8% increase year-over-year.
- Oncocyte Corp Depreciation, Depletion and Amortization for the twelve months ending September 30, 2025 was $2.2M.
- Oncocyte Corp annual Depreciation, Depletion and Amortization for 2024 was $1.56M, a 6.91% decline from 2023.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)